Atjaunināt sīkdatņu piekrišanu

E-grāmata: Investigation and Exploitation of Antibody Combining Sites

Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 53,52 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

#A Antibody Combining Sites, Especially Structure.- #A1 Antibody
combining sites past, present and future.- #A2 Variability, modelling and
prediction of ?-hairpins with reference to the immunoglobulin fold.- #A3
Probing the binding sites in crystals of immunoglobulins.- #A4 Comparative
structures of mouse antibody combining sites.- #NC(A) NOTE and COMMENTS
related to the foregoing topics*.- #NC(A)1 An approach to the study of
anti-protein antibody combining sites.- #B Production and Characterization of
Antibodies, in Contexts such as Receptor Investigation.- #B1 Investigating
the specificity of monoclonal antibodies to protein antigens using
?-galactosidase fusion proteins.- #B2 Antibody-screening cDNA libraries.-
#B3 Anti-receptor antibodies by the auto-anti-idiotypic route.- #B4
Production and characterization of anti-morphine anti-idiotypic antibodies.-
#B5 Anti-idiotype antibodies for the study of membrane receptors: the double
monoclonal antibody approach.- #NC(B) NOTES and COMMENTS related to the
foregoing topics.- #NC(B)1 Characterization of idiotypes and VH genes of
various members of A48-idiotypic network pathway.- #NC(B)2 Monoclonal
internal image anti-idiotypic antibodies of hepatitis B surface antigen.-
#NC(B)3 Structure and expression of genes encoding IgA heavy chains.-
#NC(B)4 Human:mouse antibody-producing transfectoma cell lines.- #NC(B)5
Different ways to modify monoclonal antibodies.- #NC(B)6 Restructuring
enzymes and antibodies.- #NC(B)7 Dideoxy mRNA sequencing as a method to
analyze antibody diversity.- #NC(B)8 Effect of multivalent binding on
dissociation of monoclonal antibodies from cell surface antigens.- #C
Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.-
#C1Immunological approaches and techniques employed in tubulin and
microtubule research.- #C2 Cell-surface events during myogenesis:
immunofluorescence analysis using monoclonal antibodies.- #C3 Differential
expression of cell-surface antigens on muscle satellite cells and myoblasts.-
#C4 Cholinergic-specific nerve terminal antigens.- #C5 Use of antibodies to
purify cholinergic nerve terminals.- #NC(C) NOTES and COMMENTS related to the
foregoing topics.- #NC(C)1 An immunological approach to the cell lineage
problem in the mammalian CNS.- #NC(C)2 An enzyme-linked immunosorbent assay
for calmodulin.- #NC(C)3 Intermediate filament diversity as detected by
antibodies.- #D Antibody Approaches to Membrane Components Including the
T-Cell Receptor.- #D1 Exploitation of antibodies in the study of cell
membranes.- #D2 Use of polyclonal and monoclonal antibodies in studying
complement component C9 as a transmembrane protein.- #D3 Ca2+-binding
proteins located on the cytoplasmic face of the lymphocyte plasma membrane.-
#D4 The T-cell receptor.- #NC(D) NOTES and COMMENTS related to the foregoing
topics.- #NC(D)1 New light on the T-cell receptor in relation to antibody
binding sites.- #NC(D)2 Molecular nature of the T3 antigen of human T
lymphocytes.- #NC(D)3 Organization and expression of the murine T-cell
receptor ?-chain gene complex.- #NC(D)4 Antigen-specific T-cell activation.-
#E Antibodies in Relation to Oncology.- #E1 Requirements by cancer cells for
polypeptide growth factors suggest new therapeutic strategies.- #E2
Monoclonal antibodies to human tumours for targeting cytotoxic drugs.- #E3
Antigenic modulation as a limiting factor in the treatment of B-cell lymphoma
with anti-idiotype antibody.- #E4 Tumour-associatedcarbohydrate antigens of
glycoproteins.- #E5 Glycolipid antigens: potential in cancer detection and
diagnosis.- #NC(E) NOTES and COMMENTS related to the foregoing topics.-
#NC(E)1 Immune surveillance.- #NC(E)2 WORKSHOP DISCUSSION focused on #E4,
#E5 & #E3.- Guidance for uninitiated readers.- Corrections to Vol. 13.